Conjunctivitis Treatment Market Trends

  • Report ID: 4553
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Conjunctivitis Treatment Market Trends

Growth Drivers

  • Increasing Air Pollution Across the World – Exposure to indoor or outdoor air pollution can be harmful to human eyes. Tobacco smoking, cooking, and poor indoor ventilation cause eye disorders such as glaucoma, conjunctivitis, cataracts, and age-related macular degeneration. For instance, air pollution accounts for 12% of deaths in the world, and air pollution from particulate matter 2.5 leads to allergic conjunctivitis and glaucoma.

  • Rising Burden of Bacterial Conjunctivitis Infection - There are various ways that bacterial conjunctivitis can spread from person to person. These include cross-transmission from mother to child or hand-to-eye contact as well as eye contact with contaminated objects. Large respiratory tract droplets are another way through which bacteria can spread. Conjunctivitis can also result from mutations in the conventional bacteria that inhabit the conjunctiva. Thus, the surging burden of bacterial conjunctivitis infection is another factor that is estimated to fuel the growth of the global conjunctivitis treatment market in the coming years. For instance, the cost of treatment in the U.S. for only bacterial conjunctivitis is around USD 370-850 million per year.

  • Growing Globalization and Industrialization – The number of industries across the globe grew from 320 million in 2020 to 330 million in 2021, as per the estimations.

  • Rising Cases of Neonatal Conjunctivitis – In the United States, Ophthalmia neonatorum was one of the common conditions seen in nearly 1% to 12% of neonates in 2022.

  • Elevating Ratio of Sexually Transmitted Infections (STIs) – As per the World Health Organization figures, each day, over 1 million sexually transmitted infections (STIs) are acquired throughout the world, a large percentage of which show no symptoms.

Challenges

  • Associated Adverse Effects of Drugs – Many times, some medication does not suit the sensitivity of the patient and results in some more harsh outcomes such as rashes, a temporary burning or stinging sensation in an infected eye, and sometimes an issue of unstable vision after using the prescribed eye drop or ointment. Hence, this factor is anticipated to hamper the market’s growth during the projected time frame.
  • Lack of Visits to Healthcare
  • Stringent Government Regulations for Approval of New Drugs

Conjunctivitis Treatment Market: Key Insights

Base Year

2022

Forecast Year

2023-2033

CAGR

~4%

Base Year Market Size (2022)

~ USD 5 Billion

Forecast Year Market Size (2033)

~ USD 8 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

4.4%

Base Year Market Size (2024)

USD 5.45 billion

Forecast Year Market Size (2037)

USD 9.54 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4553
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of conjunctivitis treatment is evaluated at USD 5.84 billion.

The conjunctivitis treatment market size was valued at USD 5.45 billion in 2024 and is set to exceed USD 9.54 billion by 2037, registering over 4.4% CAGR during the forecast period i.e., between 2025-2037. Increasing air pollution across the world, rising burden of bacterial conjunctivitis infection, and rising cases of neonatal conjunctivitis will boost the market growth.

North America industry is poised to hold largest revenue share of 36% by 2037, attributed majorly to increasing occurrence of conjunctivitis, coupled with growing use of corrective lenses by individuals in the region.

The major players in the market are Novartis AG, Aurobindo Pharma Limited, Cipla Limited, Viatris Inc., Akorn Operating Company LLC, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Dr.Reddy’s Laboratories Limited, MICRO LABS LIMITED, Ocular Therapeutix, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample